Author: OurCrowd

[CytoReason in Yahoo Finance] CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms

TEL AVIV, Israel, June 17, 2021 /PRNewswire/ — CytoReason, an AI company developing a computational disease model of the human body for clinical drug development, today announced the initiation of a project with French global biopharmaceutical company Sanofi, which will utilize its cell-centered models and deconvolution techniques to suggest mechanistic insights for each asthma endotype. Read...

Read More

[Nexa3D in Business Wire] Nexa3D Presents Future of AM at ASME

VENTURA, Calif.–(BUSINESS WIRE)–The ASME AM Tech Forum is an interactive one-day virtual event dedicated to tech product discovery. Held on June 17, 2021, all industries will be featured. At the event, companies are invited to compare solutions side-by-side with product demonstrations and launches. The event also enables professionals to connect with solution providers as part of a live competition. Read...

Read More